Bristol-Myers Squibb Company (TSX:BMY)
Canada · Delayed Price · Currency is CAD 22.75
-0.31 (-1.34%)
Nov 10, 2026, 9:50 AM EST
TSX:BMY Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 50,033 | 48,194 | 48,300 | 45,006 | 46,159 | 46,385 |
Revenue Growth | 4.16% | -0.22% | 7.32% | -2.50% | -0.49% | 9.10% |
Gross Profit Gross Profit Growth | 35,275 | 35,000 | 36,351 | 34,377 | 36,022 | 36,445 |
Operating Income Operating Income Growth | 16,193 | 15,039 | 9,832 | 8,365 | 9,141 | 8,572 |
Net Income Net Income Growth | 9,243 | 7,054 | -8,948 | 8,025 | 6,327 | 6,994 |
Earnings Per Share EPS Growth | 4.51 | 3.46 | -4.41 | 3.86 | 2.95 | 3.12 |
EPS Growth | 51.92% | - | - | 30.85% | -5.45% | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Product Net Product Growth | 48,473 | 46,756 | 46,778 | 43,778 | 44,671 | 45,055 |
Alliance & Other Alliance & Other Growth | 1,560 | 1,438 | 1,522 | 1,228 | 1,488 | 1,330 |
Revenue (Total) Revenue (Total) Growth | 50,033 | 48,194 | 48,300 | 45,006 | 46,159 | 46,385 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 12,959 | 11,069 | 11,179 | 12,644 | 9,253 | 17,221 |
Total Debt Total Debt Growth | 44,810 | 47,187 | 51,237 | 41,507 | 40,820 | 45,596 |
Net Cash (Debt) Net Cash Growth | -31,851 | -36,118 | -40,058 | -28,863 | -31,567 | -28,375 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -15.56 | -17.71 | -19.76 | -13.89 | -14.71 | -12.64 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 10,652 | 14,156 | 15,190 | 13,860 | 13,066 | 16,207 |
Capital Expenditures CapEx Growth | -1,366 | -1,311 | -1,248 | -1,209 | -1,118 | -973 |
Free Cash Flow Free Cash Flow Growth | 9,286 | 12,845 | 13,942 | 12,651 | 11,948 | 15,234 |
Free Cash Flow Growth | -39.31% | -7.87% | 10.21% | 5.88% | -21.57% | 14.55% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 70.50% | 72.62% | 75.26% | 76.38% | 78.04% | 78.57% |
Operating Margin | 32.37% | 31.20% | 20.36% | 18.59% | 19.80% | 18.48% |
Pretax Margin | 22.65% | 19.36% | -17.35% | 18.75% | 16.71% | 17.46% |
Profit Margin | 18.47% | 14.64% | -18.53% | 17.83% | 13.71% | 15.08% |
FCF Margin | 18.56% | 26.65% | 28.87% | 28.11% | 25.88% | 32.84% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.58 | 15.57 | - | 13.01 | 25.24 | 19.79 |
P/FCF Ratio | 13.61 | 8.55 | 8.23 | 8.25 | 13.37 | 9.09 |
PS Ratio | 2.53 | 2.28 | 2.38 | 2.32 | 3.46 | 2.98 |